News / Events :: BioXcel Therapeutics, Inc. (BTAI)

Recent News View All News

BioXcel Therapeutics Reports Third Quarter 2018 Quarterly Results and Provides Business Update

November 9, 2018

BioXcel Therapeutics Announces FDA Acceptance of IND for Lead Immuno-oncology Candidate, BXCL701, in Treatment Emergent Neuroendocrine Prostate Cancer

November 5, 2018

Recent Events View IR Calendar

Third Quarter 2018 Financial Results Conference Call

Nov 9, 2018 • 8:00am EST

Society for Immunotherapy of Cancer (SITC) 33rd Annual Meeting

Nov 7 – Nov 11, 2018

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings